Investor centre
Latest regulatory news
| 08/09/2010 | s phase III trial of AS1413 completes patient enrolment |
| 02/09/2010 | Antisoma Annual Report and Accounts 2010 |
| 01/09/2010 | Fees in Shares and Total Voting Rights |
More regulatory announcements
Latest corporate presentation
| 23/06/2010 | Piper Jaffray conference webcast |
| 10/06/2010 | Needham conference webcast |
IR contacts
For investor relations enquiries please contact:Alison Saville
Tel: +44 (0) 20 3249 2100
Fax: +44 (0) 20 3249 2101
enquiries@antisoma.com
Registered Office: Chiswick Park Building 5, 566 Chiswick High Road, London W4 5YF, UK
Registered in England and Wales No. 3248123